LITTLE ROCK, Ark.--(BUSINESS WIRE)--Vivione Biosciences Inc. (“Vivione”) (TSXV:VBI), through its wholly owned subsidiary Vivione Biosciences, LLC, is proud to announce that it has received AOAC (Association of Analytical Communities) certification for its E. coli O157 and Non O157 STEC diagnostic tests for the RAPID-B platform. This is Vivione’s first AOAC certification for its RAPID-B platform, whose technology has the ability to accurately detect a contamination issue in seven hours or less.
Help employers find you! Check out all the jobs and post your resume.
